Blog
RSS FeedPosted by Michael Wonder on 16 Sep 2022
PHARMAC can't progress cystic fibrosis drug Trikafta - CF New Zealand
16 September 2022 - PHARMAC is not in a position to progress funding on the life-extending cystic fibrosis drug, Trikafta, ...
Posted by Michael Wonder on 15 Sep 2022
Can the proposed listing of two medicines from the same supplier really be called a bundle deal?
16 September 2022 - On Wednesday, PHARMAC announced a "medicines bundle to provide more treatment options for New Zealanders." ...
Posted by Michael Wonder on 15 Sep 2022
Advocates welcome PHARMAC's removal of barriers to menopausal symptoms treatment
15 September 2022 - A women's health expert says today marks a major win for wāhine in Aotearoa, with PHARMAC ...
Posted by Michael Wonder on 15 Sep 2022
Progesterone to be fully funded for all who need it
15 September 2022 - PHARMAC has today confirmed that it is removing all funding restrictions from progesterone, with tens of thousands ...
Posted by Michael Wonder on 14 Sep 2022
PHARMAC announces medicines bundle to provide more treatment options for New Zealanders
14 September 2022 - PHARMAC is considering funding two medicines as part of a new bundle agreement that would offer ...
Posted by Michael Wonder on 13 Sep 2022
Family of baby spending first birthday in hospital with pneumococcal complications calls for vaccine switch
13 September 2022 - At first, doctors thought it was a common virus. Baby Eloise Swadel had a cough and ...
Posted by Michael Wonder on 12 Sep 2022
Blood cancer patient charity campaigns for PHARMAC to fund medicine
12 September 2022 - Blood cancer patients are urging PHARMAC to fund a medicine that would restore the quality of life ...
Posted by Michael Wonder on 12 Sep 2022
PHARMAC simplifies criteria for COVID-19 anti-viral treatments
12 September 2022 - PHARMAC has confirmed today that it is simplifying the access criteria for the three anti-viral treatments it ...
Posted by Michael Wonder on 08 Sep 2022
Pharmac issues RFP for intravenous trastuzumab, a medicine used to treat breast cancer
8 September 2022 - PHARMAC is seeking commercial bids from pharmaceutical suppliers for the supply of intravenous trastuzumab, a ‘biologic’ ...
Posted by Michael Wonder on 07 Sep 2022
Doctors call for vaccine u-turn from PHARMAC after surge in preventable pneumococcal cases
8 September 2022 - When drug-buying agency PHARMAC switched to a cheaper vaccine covering fewer strains of potentially deadly pneumococcal ...
Posted by Michael Wonder on 07 Sep 2022
Blood cancer patients implore PHARMAC to fund desperately needed medicine
7 September 2022 - New Zealanders living with multiple myeloma are mounting a major, evidence-based campaign to press PHARMAC into funding ...
Posted by Michael Wonder on 06 Sep 2022
PHARMAC capable of managing medical devices supply chain, it says
6 September 2022 - PHARMAC says it has saved $100 million since 2014 by doing deals to cut the price ...
Posted by Michael Wonder on 05 Sep 2022
PHARMAC promises equity boost in first official response to independent review
6 September 2022 - PHARMAC will supercharge its commitment to Māori and diverse communities, which could see different medicines funded, ...
Posted by Michael Wonder on 05 Sep 2022
PHARMAC releases its interim response following PHARMAC review
5 September 2022 - As part of its ongoing commitment to transparency, Te Pātaka Whaioranga – PHARMAC has today shared their ...
Posted by Michael Wonder on 03 Sep 2022
Every life is worth the same, but maybe not at PHARMAC
4 September 2022 - One of the dubious consequences of our obsession with race is the collection of data on ...